» Articles » PMID: 31014980

Comparison of Orthogonal NLP Methods for Clinical Phenotyping and Assessment of Bone Scan Utilization Among Prostate Cancer Patients

Overview
Journal J Biomed Inform
Publisher Elsevier
Date 2019 Apr 25
PMID 31014980
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Clinical care guidelines recommend that newly diagnosed prostate cancer patients at high risk for metastatic spread receive a bone scan prior to treatment and that low risk patients not receive it. The objective was to develop an automated pipeline to interrogate heterogeneous data to evaluate the use of bone scans using a two different Natural Language Processing (NLP) approaches.

Materials And Methods: Our cohort was divided into risk groups based on Electronic Health Records (EHR). Information on bone scan utilization was identified in both structured data and free text from clinical notes. Our pipeline annotated sentences with a combination of a rule-based method using the ConText algorithm (a generalization of NegEx) and a Convolutional Neural Network (CNN) method using word2vec to produce word embeddings.

Results: A total of 5500 patients and 369,764 notes were included in the study. A total of 39% of patients were high-risk and 73% of these received a bone scan; of the 18% low risk patients, 10% received one. The accuracy of CNN model outperformed the rule-based model one (F-measure = 0.918 and 0.897 respectively). We demonstrate a combination of both models could maximize precision or recall, based on the study question.

Conclusion: Using structured data, we accurately classified patients' cancer risk group, identified bone scan documentation with two NLP methods, and evaluated guideline adherence. Our pipeline can be used to provide concrete feedback to clinicians and guide treatment decisions.

Citing Articles

Applying Natural Language Processing to Textual Data From Clinical Data Warehouses: Systematic Review.

Bazoge A, Morin E, Daille B, Gourraud P JMIR Med Inform. 2023; 11:e42477.

PMID: 38100200 PMC: 10757232. DOI: 10.2196/42477.


The Coming of Age of AI/ML in Drug Discovery, Development, Clinical Testing, and Manufacturing: The FDA Perspectives.

Niazi S Drug Des Devel Ther. 2023; 17:2691-2725.

PMID: 37701048 PMC: 10493153. DOI: 10.2147/DDDT.S424991.


A cross-institutional evaluation on breast cancer phenotyping NLP algorithms on electronic health records.

Zhou S, Wang N, Wang L, Sun J, Blaes A, Liu H Comput Struct Biotechnol J. 2023; 22:32-40.

PMID: 37680211 PMC: 10480628. DOI: 10.1016/j.csbj.2023.08.018.


Assessment of Electronic Health Record for Cancer Research and Patient Care Through a Scoping Review of Cancer Natural Language Processing.

Wang L, Fu S, Wen A, Ruan X, He H, Liu S JCO Clin Cancer Inform. 2022; 6:e2200006.

PMID: 35917480 PMC: 9470142. DOI: 10.1200/CCI.22.00006.


Expanding the Secondary Use of Prostate Cancer Real World Data: Automated Classifiers for Clinical and Pathological Stage.

Bozkurt S, Magnani C, Seneviratne M, Brooks J, Hernandez-Boussard T Front Digit Health. 2022; 4:793316.

PMID: 35721793 PMC: 9201076. DOI: 10.3389/fdgth.2022.793316.


References
1.
Albert J, Das P . Quality indicators in radiation oncology. Int J Radiat Oncol Biol Phys. 2012; 85(4):904-11. DOI: 10.1016/j.ijrobp.2012.08.038. View

2.
Wagholikar K, MacLaughlin K, Henry M, Greenes R, Hankey R, Liu H . Clinical decision support with automated text processing for cervical cancer screening. J Am Med Inform Assoc. 2012; 19(5):833-9. PMC: 3422840. DOI: 10.1136/amiajnl-2012-000820. View

3.
Anumula N, Sanelli P . Physician Quality Reporting System. AJNR Am J Neuroradiol. 2011; 32(11):2000-1. PMC: 7964408. DOI: 10.3174/ajnr.A2912. View

4.
Yim W, Wheeler A, Curtin C, Wagner T, Hernandez-Boussard T . Secondary use of electronic medical records for clinical research: Challenges and Opportunities. Converg Sci Phys Oncol. 2018; 4(1). PMC: 5933881. DOI: 10.1088/2057-1739/aaa905. View

5.
Filson C . Quality of care and economic considerations of active surveillance of men with prostate cancer. Transl Androl Urol. 2018; 7(2):203-213. PMC: 5911536. DOI: 10.21037/tau.2017.08.08. View